On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

Predictive Oncology Inc. (NASDAQ: POAI) Utilizes Proprietary Dataset to Revolutionize Treatment Outcomes for Cancer

Predictive Oncology is working to develop highly customizable assessment methods to individualize treatment options for cancer, improving outcomes POAI’s innovative technology is pioneering in the field of individualizing treatment for ovarian cancer Predictive Oncology offers potential for significant ROI as it focuses on improving outcomes for cancer patients of today and tomorrow Predictive Oncology Inc. … Continue reading “Predictive Oncology Inc. (NASDAQ: POAI) Utilizes Proprietary Dataset to Revolutionize Treatment Outcomes for Cancer”

NetworkNewsBreaks – Why Predictive Oncology Inc. (NASDAQ: POAI) Is ‘One to Watch’

Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted … Continue reading “NetworkNewsBreaks – Why Predictive Oncology Inc. (NASDAQ: POAI) Is ‘One to Watch’”

Predictive Oncology Inc. (NASDAQ: POAI) is “One to Watch”

Helomics is collaborating with the University of Pittsburgh School of Medicine to study the use of artificial intelligence to improve clinical decision making for ovarian cancer patients. More than 22,000 women are diagnosed with ovarian cancer in the U.S. each year. Entered an agreement with Interpace Diagnostics Group Inc. (IDXG) and Helomics to develop products … Continue reading “Predictive Oncology Inc. (NASDAQ: POAI) is “One to Watch””

Predictive Oncology (NASDAQ: POAI)

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for … Continue reading “Predictive Oncology (NASDAQ: POAI)”

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Report Q2 2019 Results, Host Conference Call after Market Close

Predictive Oncology Inc. (NASDAQ: POAI), an artificial intelligence (AI) and data-driven functional precision medicine company, this morning announced that it will report its financial results for the fiscal quarter ended June 30, 2019, after market close today, August 19. Per the update, the company’s management team will host a conference call to review the financial … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Report Q2 2019 Results, Host Conference Call after Market Close”

NetworkNewsBreaks – Predictive Oncology, Inc. (NASDAQ: POAI) Subsidiary Partners with UPMC to Develop AI-Powered Method to Treat Ovarian Cancer

Predictive Oncology’s (NASDAQ: POAI) subsidiary Helomics in July announced a joint collaborative agreement with the University of Pittsburgh School of Medicine (“UPMC”) to study the use of Helomics’ artificial intelligence (“AI”) platform (D-CHIP)(TM) to improve clinical decision making for ovarian cancer patients. The platform will be employed to analyze the genomic and drug response profiles … Continue reading “NetworkNewsBreaks – Predictive Oncology, Inc. (NASDAQ: POAI) Subsidiary Partners with UPMC to Develop AI-Powered Method to Treat Ovarian Cancer”

NetworkNewsBreaks – Predictive Oncology, Inc.’s (NASDAQ: POAI) Skyline Medical Division Receives First Order of STREAMWAY Systems in India

Predictive Oncology (NASDAQ: POAI) recently announced the receipt of its Skyline Medical division’s first order of STREAMWAY Systems from India. Skyline’s groundbreaking, FDA-cleared STREAMWAY System is a direct-to-drain fluid disposal system intended specifically for medical applications. The order was made for four machines to be sold to local Indian hospitals. “The sale of these four … Continue reading “NetworkNewsBreaks – Predictive Oncology, Inc.’s (NASDAQ: POAI) Skyline Medical Division Receives First Order of STREAMWAY Systems in India”

Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics

NetworkNewsWire Editorial Coverage: The field of precision medicine has latched upon what may well be the Holy Grail in the fight against cancer. When big data are utilized by teams of pathologists, data can be incredibly helpful, but when the right data are comprehensively analyzed by artificial intelligence (AI)-powered models, the data can be downright … Continue reading “Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics”

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217